Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein

Biochemical Pharmacology
A F Castro, G A Altenberg

Abstract

It has been claimed that the flavonoid genistein could be used to distinguish multidrug-resistant tumors expressing the multidrug resistance-associated protein (MRP) from those expressing P-glycoprotein (Pgp). Genistein would be block drug transport by MRP without affecting Pgp-mediated drug transport. However, we found that exposure to 200 microM genistein elicited an elevation in intracellular accumulation of rhodamine 123 (R123) and daunorubicin (DNR) in Pgp-expressing cell lines. Genistein inhibited R123 efflux in a rapidly reversible manner (ca. 2 min). The flavonoid also decreased photoaffinity labeling of Pgp by [3H]azidopine, a Pgp substrate. The present results show that genistein interacts with Pgp and inhibits Pgp-mediated drug transport. Hence, genistein cannot be used in simple assays to distinguish MRP- and Pgp-expressing cells.

References

Feb 1, 1995·Journal of Bioenergetics and Biomembranes·U A GermannM M Gottesman
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P R TwentymanS Rayner
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan

❮ Previous
Next ❯

Citations

Apr 13, 2005·Cancer Chemotherapy and Pharmacology·Chantal BarthomeufRichard Béliveau
Jan 13, 2005·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Adam K GreenWilliam H Karasov
Mar 30, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Feng QianShengli Yang
Dec 31, 2003·Life Sciences·Yao-Horng WangYu-Chi Hou
Jun 13, 2002·Il Farmaco·E TeodoriF Gualtieri
Feb 21, 2002·Biochimica Et Biophysica Acta·Julie JodoinRichard Beliveau
May 3, 2003·Journal of Experimental Therapeutics & Oncology·John A Kellen
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·G ConseilA Di Pietro
Nov 18, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M KolaczkowskiA Goffeau
Jan 6, 2006·Biological & Pharmaceutical Bulletin·Shuji Kitagawa
Jun 17, 2003·Chemical & Pharmaceutical Bulletin·Chatchanok LoetchutinatSamlee Mankhetkorn
Mar 17, 2001·Environmental Health Perspectives·P L Whitten, H B Patisaul
Jan 31, 2014·Journal of Medicinal Food·Chukwuemezie ChimezieRobert E Stratford
Sep 11, 2014·Interdisciplinary Sciences, Computational Life Sciences·Jayasimha Rayalu DaddamPramodakumari Jasti
Dec 26, 2015·International Journal of Environmental Research and Public Health·Chandler Schexnayder, Robert E Stratford
Jun 23, 2009·Journal of Pharmaceutical Sciences·Ana I AlvarezGracia Merino
Oct 28, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J-S Taur, R Rodriguez-Proteau
Nov 2, 2004·Journal of Cellular Biochemistry·Maria V CamarasaJose A Ferragut
Mar 5, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Jun YuWei Wei
Nov 26, 2015·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Grégory GatouillatClaudie Madoulet
Feb 3, 2007·International Journal of Pharmaceutics·Xiuguo Li, Jun-Shik Choi
Aug 3, 2004·The Journal of Pharmacy and Pharmacology·Shuji KitagawaShizu Kamiyama
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Shuji KitagawaYoshiki Kashiwada
Nov 10, 2010·Biomedical Chromatography : BMC·Nuggehally R Srinivas, Ramesh Mullangi
Feb 4, 2006·Life Sciences·Marilyn E Morris, Shuzhong Zhang
Sep 6, 2005·Biochemical Pharmacology·Shuji KitagawaYasumasa Ikeshiro
Nov 26, 1999·Biochemical Pharmacology·A F CastroG A Altenberg
Nov 21, 2008·Cellular & Molecular Biology Letters·Olga WesołowskaKrystyna Michalak
Jan 1, 2014·Environmental Toxicology and Chemistry·Anastasia GeorgantzopoulouAlbertinka J Murk
Aug 1, 2006·Drug Metabolism Reviews·Carolien J P van den Bout-van den BeukelDavid M Burger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.